(Q41018603)

25 September 2017

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein (English)

1 reference

25 September 2017

0 references

1 reference

Wakasugi H

1

1 reference

25 September 2017

Yano I

2

1 reference

25 September 2017

Ito T

3

1 reference

25 September 2017

Hashida T

4

1 reference

25 September 2017

Futami T

5

1 reference

25 September 2017

Nohara R

6

1 reference

25 September 2017

Sasayama S

7

1 reference

25 September 2017

Inui K

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

Clinical Pharmacology & Therapeutics

25 September 2017

1 reference

25 September 2017

64

1 reference

25 September 2017

123-128

1 reference

25 September 2017

1

1 reference

Clarithromycin-associated digoxin toxicity in the elderly

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Clarithromycin-related toxic effects of digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Clarithromycin-induced digoxin toxicity in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Digoxin toxicity secondary to clarithromycin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Erythromycin-induced digoxin toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Digoxin toxicity due to interaction of digoxin with erythromycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Inactivation of Digoxin by the Gut Flora: Reversal by Antibiotic Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Reversal of drug resistance by erythromycin: erythromycin increases the accumulation of actinomycin D and doxorubicin in multidrug-resistant cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

A new enzymatic serum creatinine measurement based on an endogenous creatine-eliminating system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990030-3

10.1016/S0009-9236(98)90030-3

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference